Human T-cell leukaemia/lymphoma virus type 1 syncytium formation is regulated in a cell-specific manner by ICAM-1, ICAM-3 and VCAM-1 and can be inhibited by antibodies to integrin beta2 or beta7.
(Q38960100)
scientific article published on June 1999
scientific article published on June 1999
Language:
| (P31) |
(Q13442814)
|
||||||||||||||||||||||||
| (P304) |
1429-1436
|
||||||||||||||||||||||||
| (P407) |
(Q1860)
|
||||||||||||||||||||||||
| (P478) |
80 ( Pt 6)
|
||||||||||||||||||||||||
| (P577) |
Tuesday, June 1, 1999
|
||||||||||||||||||||||||
| (P921) |
(Q79460)
(Q29496)
|
||||||||||||||||||||||||
| (P1433) |
(Q6295245)
|
||||||||||||||||||||||||
| (P1476) |
"Human T-cell leukaemia/lymphoma virus type 1 syncytium formation is regulated in a cell-specific manner by ICAM-1, ICAM-3 and VCAM-1 and can be inhibited by antibodies to integrin beta2 or beta7." (language: en)
|
||||||||||||||||||||||||
| (P2093) |
Daenke S
McCracken SA
Booth S
|